CeNeRx BioPharma
Closed portfolio with an early-phase archive tilt
According to ClinicalTrials.gov-derived indexes, CeNeRx BioPharma sits in the upper quartile of US sponsors by registered trial count (#2,913 of 15,742 sponsors by registered trial count).
CeNeRx BioPharma: 4 sponsored US clinical trials, none currently recruiting.
CeNeRx BioPharma sponsors 4 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 4 completed. 0 of these trials are in Phase 3-4 (later-stage) and 4 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Major Depressive Disorder, with 1 trials.
Upper-quartile sponsor footprint
CeNeRx BioPharma sits in the upper quartile of the sponsor corpus (#2,913 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Indexed trials (enrollment closed)
4 total, page 1 of 1
Efficacy, Safety and Tolerability of CX157 in Treatment Resistant Depression
NCT01246908
Oral Tyramine Pressor Response Study of CX157 Tablets in Healthy Male Volunteers
NCT01633437
Examining the Effects of CXB722 in Neuroendocrine Stress Response in Healthy Males
NCT00814931
A Study of CX157 (TriRima) for the Treatment of Depression
NCT00739908
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
| Phase 2 | 2 |
Therapeutic Areas
How the CeNeRx BioPharma early-phase archive is shaped
4 indexed studies, none listed as recruiting (0% open); 4 completed (100%).
Phase mix: 0 late (III/IV) vs 4 early (I/II) (early-phase heavy).
Top condition: Major Depressive Disorder (1 trial), 0 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
CeNeRx BioPharma: archived-pipeline peers nationwide
Peers matched on 4 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
CeNeRx BioPharma sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 4 archived trials
- 4D pharma · 4 trials · 0% recruiting
- 60 Degrees Pharmaceuticals · 4 trials · 50% recruiting
- A2 Biotherapeutics · 4 trials · 75% recruiting
- Abdul Latif Jameel Poverty Action Lab · 4 trials · 25% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this CeNeRx BioPharma page
4 registered trials is a research-attention snapshot, not an endorsement of CeNeRx BioPharma or any single study.
- None of CeNeRx BioPharma's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Major Depressive Disorder is the condition CeNeRx BioPharma studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Major Depressive Disorder trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
CeNeRx BioPharma pipeline card: 4 registered trials from official public datasets.Report a data error.